Symbol="OCUP"
AssetType="Common Stock"
Name="Ocuphire Pharma Inc"
Description="Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of various eye disorders. The company is headquartered in Farmington Hills, Michigan."
CIK="1228627"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="15245 SHADY GROVE ROAD, SUITE 455, ROCKVILLE, MD, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="82447000"
EBITDA="18607000"
PERatio="3.896"
PEGRatio="None"
BookValue="1.969"
DividendPerShare="0"
DividendYield="0"
EPS="1.01"
RevenuePerShareTTM="2.035"
ProfitMargin="0.449"
OperatingMarginTTM="0.447"
ReturnOnAssetsTTM="0.353"
ReturnOnEquityTTM="0.639"
RevenueTTM="41599000"
GrossProfitTTM="-14584000"
DilutedEPSTTM="1.01"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="20.2"
TrailingPE="3.896"
ForwardPE="-"
PriceToSalesRatioTTM="92.17"
PriceToBookRatio="5.4"
EVToRevenue="52.97"
EVToEBITDA="-2.01"
Beta="0.105"
num_52WeekHigh="6.6"
num_52WeekLow="1.81"
num_50DayMovingAverage="4.444"
num_200DayMovingAverage="3.607"
SharesOutstanding="20952200"
DividendDate="2020-11-06"
ExDividendDate="None"
symbol="OCUP"
open="4.02"
high="4.26"
low="3.96"
price="4.24"
volume="226791.00"
latest_trading_day="2023-07-13"
previous_close="3.98"
change="0.27"
change_percent="6.6667%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="16"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="84"
Volume_recent_avg="289109"
Change_recent_avg="0.01"
Delta_recent_avg="0.34"
Variance_recent_avg="0.17"
Change_ratio_recent_avg="-0.19"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="84"
Aroon_momentum_negative="16"
image_negative_thumbnail_id_1="1150"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0183.jpeg"
image_negative_thumbnail_id_2="1138"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0171.jpeg"
image_neutral_thumbnail_id_1="567"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0032.jpeg"
image_neutral_thumbnail_id_2="565"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0034.jpeg"
image_positive_thumbnail_id_1="627"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0081.jpeg"
image_positive_thumbnail_id_2="957"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0119.jpeg"
image_professor_thumbnail_id_1="1170"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
image_professor_thumbnail_id_2="1167"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0001.jpeg"
